Shaded region shows the widening gap
In one study, microdosing GLP-1s supported moderate weight loss of up to 10 pounds over 40 weeks in participants. MICRODOSING GLP-1 BENEFITS Do More, Age Less Modulated inflammatory pathways in clinical trials. Studies found a reduced risk of cognitive decline Supported cardiovascular health in clinical trials Improved mitochondrial function and oxidative stress in clinical trials Low doses reduced side effects in clinical trials Supported moderate weight loss of up to 10 pounds over 40 weeks in one study *See studies cited below
The peer-reviewed findings will be presented on Saturday (June 13) at ENDO 2026, the Endocrine Society's annual meeting
Our experience shows that labs achieving the most consistent, high-quality data are those with unflinching, standardized protocols for every step, starting with reconstitution
This would accelerate the political backlash, strengthen the case for reference pricing, and drive demand toward compounded alternatives
doi: 10.1111/bph.15603, 13 BroideE.BlochO.Ben-YehudahG.CantrellD.ShirinH.RapoportM